Standard BioTools Inc. Standard and Extended Product Warranty Accrual
Standard BioTools Inc. (LAB) had Standard and Extended Product Warranty Accrual of $536.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Payables and Accruals
us-gaap:ProductWarrantyAccrual · last filed 2022-11-09
- 2022-09-30: Standard and Extended Product Warranty Accrual $536.00K.
- 2022-06-30: Standard and Extended Product Warranty Accrual $1.15M.
- 2022-03-31: Standard and Extended Product Warranty Accrual $1.21M.
- 2021-12-31: Standard and Extended Product Warranty Accrual $1.17M.
| Period end | Standard and Extended Product Warranty Accrual | Standard and Extended Product Warranty Accrual as first filed |
|---|---|---|
| 2022-09-30 | $536.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.15M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.21M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.17M 10-Q · filed 2022-11-09 | |
| 2021-09-30 | $1.50M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $1.36M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $1.28M 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $1.66M 10-Q · filed 2022-11-09 | |
| 2020-09-30 | $1.68M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $1.53M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $1.46M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $1.39M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $1.11M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $1.09M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $930.00K 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $863.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | $741.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $608.00K 10-Q · filed 2019-11-08 | $609.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $591.00K 10-Q · filed 2019-08-07 | |
| 2017-12-31 | $699.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $693.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $706.00K 10-Q · filed 2018-11-06 | |
| 2017-03-31 | $864.00K 10-Q · filed 2018-08-08 | |
| 2016-12-31 | $1.02M 10-K · filed 2019-03-18 | |
| 2016-09-30 | $886.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $1.05M 10-Q · filed 2017-11-07 | |
| 2016-03-31 | $1.06M 10-Q · filed 2017-08-08 | |
| 2015-12-31 | $1.08M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $1.02M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $1.05M 10-Q · filed 2016-11-09 | |
| 2015-03-31 | $1.06M 10-Q · filed 2016-08-09 | |
| 2014-12-31 | $1.18M 10-K · filed 2017-03-03 | |
| 2014-09-30 | $1.29M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $1.09M 10-Q · filed 2015-11-09 | |
| 2014-03-31 | $1.11M 10-Q · filed 2015-08-10 | |
| 2013-12-31 | $344.00K 10-K · filed 2016-02-29 | $300.00K 10-K · filed 2014-03-12 |
| 2013-09-30 | $313.00K 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $288.00K 10-Q · filed 2014-11-06 | |
| 2013-03-31 | $252.00K 10-Q · filed 2014-08-04 | |
| 2012-12-31 | $257.00K 10-K · filed 2015-02-26 | $300.00K 10-K · filed 2013-03-12 |
| 2011-12-31 | $300.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |